NL-OMON20140RecruitingNot Applicable
ltra-high B-value diffusion weighted magnetic resonance imaging; the added value at 1.5T
Zuyderland Medical Centre, Heerlen, Netherlands0 sites25 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 25
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •patients with increased PSA serum values, patients with known and proven prostate cancer, patients with benign prostate hyperplasia
Exclusion Criteria
- •patients with contradictory medical, images with movement artifacts
Investigators
Similar Trials
Completed
Phase 3
Effect of PMZ-2010 in Hypovolemic Shock patients.CTRI/2019/01/017196Pharmazz India Private Limited105
Completed
Phase 3
DB2116134: A randomized, multi-center, double-blind, double-dummy, parallel group study to evaluate the efficacy and safety of umeclidinium/vilanterol compared with fluticasone propionate/salmeterol over 12 weeks in subjects with COPDNL-OMON38572GlaxoSmithKline BV65
Recruiting
Not Applicable
Effectiveness of supplementation of Nefrosave® in Chronic Kidney DiseaseCTRI/2020/04/024476Fourrts India Laboratories Pvt Ltd
Not yet recruiting
Phase 3
postoperative paiCTRI/2019/02/017850Akums Drugs Pharmaceutical Ltd India
Not yet recruiting
Phase 3
A multicentre, multinational, randomizedm Double-Blind, Placebo Controlled, crossover trial to evaluate efficacy and safety of Fentanyl TAIFUN ® treatment after titrated dose administration for breakthrough pain in cancer patients on maintenance opioid therapyCTRI/2009/091/000243Akela Pharma INC180